Insurance companies scrambling to support need for GLP-1 drugs The overwhelming popularity of GLP-1 drugs what President Trump calls the fat shot has insurance companies scrambling to satisfy consumer access to the treatments while at the same time reining in their exorbitant costs
GLP-1 is an incretin hormone produced by intestinal L-cells that regulates blood glucose, stimulates insulin secretion, and promotes satiety
For decades, we relied on the magic of glycemic control and control of hypertension to turn the tide of worsening DKD, only to see some patients with decent HbA1Cs still suffer from a decline of kidney function
They may reduce hunger, improve satiety, and help patients eat smaller portions
Mounjaro 10 mg, 15 mg, or 5 mg led to a weight loss ranging from 7.7 kg (17 lb) to 11.4 kg (25 lb), compared to semaglutide (5.9 kg, 13 lb)